Skip to main content

IB Acquisition Corp.

IBAC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001998781

No open-market purchases or sales by IB Acquisition Corp. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $1.03M in total; no superinvestor holds it.

Other share classesIBACR

Q1 2026 vs. Q4 2025

How the institutions holding IB Acquisition Corp. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of IBAC: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders126−6
Shares1.18M96.4K−1.08M (−91.8%)
Value$12.3M$1.03M−$11.3M (−91.7%)

New holders (1)

Institutions that held IB Acquisition Corp. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to IBAC in Q1 2026
InstitutionSharesValue% of portfolio
Jane Street Group, LLC20,373$217.2K0.00%

Sold out (7)

Institutions that held IB Acquisition Corp. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of IBAC in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
CNH Partners LLC688,646$7.23M
Wolverine Asset Management LLC140,000$1.47M
Crossingbridge Advisors, LLC70,000$735.0K
Virtu Financial LLC42,298$444.0K
Goldman Sachs Group Inc27,866$292.6K
Abc Arbitrage SA20,000$210.0K
Susquehanna International Group, LLP18,172$190.8K